zalcitabine has been researched along with Sensitivity and Specificity in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Cabrera, AJ; Dang, CH; Frenkel, LM; Jerome, KR; Lin, CH; Sloan, DD; Tobin, NH; Wagner, T | 1 |
| Casula, M; de Ronde, A; Goudsmit, J; Lange, JM; Reiss, P; Weverling, GJ | 1 |
| Acosta, EP; Bennetto-Hood, C; Long, MC | 1 |
| Beijnen, JH; Bult, A; Burger, DM; Duyts, T; Koks, CH; Meenhorst, PL; Mulder, JW; Rosing, H; ten Napel, CH | 1 |
| Daniel, MJ; Gray, MR; Jenner, WN; Newman, JJ; O'Neill, RM; Sutherland, DR; Wells, GN; Williams, JL; Wring, SA | 1 |
| Anderson, BD; Kojima, E; Mitsuya, H; Shirasaka, T; Yarchoan, R | 1 |
| Evans, GL; Harker, AJ; Hawley, AE; Morris, DM | 1 |
| Hsyu, PH; Lloyd, TL | 1 |
| Buckley, TJ; Jatlow, PI; Rainey, PM; Roberts, WL | 1 |
| Clements, J; Clive, D; Elliott, BM; Green, M; Honma, M; Müller, L; San, RH; Shimada, H; Sofuni, T; Thybaud, V; Wilcox, P | 1 |
| Chan, HL; Lau, TC; Leung, NW; Sung, JJ; Wong, ML | 1 |
| Mancini, WR | 1 |
1 trial(s) available for zalcitabine and Sensitivity and Specificity
| Article | Year |
|---|---|
Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy.
Topics: Antiviral Agents; DNA, Viral; Emtricitabine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Nucleic Acid Hybridization; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Zalcitabine | 2000 |
12 other study(ies) available for zalcitabine and Sensitivity and Specificity
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Assessment of mitochondrial toxicity by analysis of mitochondrial protein expression in mononuclear cells.
Topics: Adenosine Triphosphatases; Adult; Child; Child, Preschool; DNA, Mitochondrial; Dose-Response Relationship, Drug; Electron Transport Complex IV; Ethidium; Flow Cytometry; Humans; Infant; Leukocytes, Mononuclear; Middle Aged; Mitochondria; Mitochondrial Proteins; Reproducibility of Results; Sensitivity and Specificity; Young Adult; Zalcitabine | 2009 |
Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors.
Topics: Analysis of Variance; Anti-HIV Agents; Didanosine; DNA, Mitochondrial; Drug Combinations; HIV Infections; Humans; Mitochondrial Diseases; Reverse Transcriptase Inhibitors; Self-Sustained Sequence Replication; Sensitivity and Specificity; Zalcitabine; Zidovudine | 2004 |
Development of a sensitive and specific liquid chromatography/mass spectrometry method for the determination of tenofovir in human plasma.
Topics: Adenine; Calibration; Chromatography, Liquid; Drug Stability; Freezing; Humans; Molecular Structure; Organophosphonates; Reference Standards; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Temperature; Tenofovir; Time Factors; Zalcitabine | 2007 |
Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluid.
Topics: Humans; Middle Aged; Radioimmunoassay; Sensitivity and Specificity; Zalcitabine | 1994 |
The production and evaluation of a radioligand and antiserum for the radioimmunoassay of subnanogram per millilitre concentrations of lamivudine.
Topics: Animals; Cross Reactions; Immune Sera; Lamivudine; Ligands; Mass Spectrometry; Nucleotides; Radioimmunoassay; Sensitivity and Specificity; Sheep; Zalcitabine | 1994 |
Identification of drug-related genotypic changes in HIV-1 from serum using the selective polymerase chain reaction.
Topics: Antiviral Agents; Base Sequence; Didanosine; DNA Primers; DNA, Viral; Efficiency; Evaluation Studies as Topic; Genes, pol; Genotype; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Proviruses; Reproducibility of Results; RNA, Viral; Sensitivity and Specificity; Templates, Genetic; Virion; Zalcitabine; Zidovudine | 1994 |
High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum.
Topics: Antiviral Agents; Autoanalysis; Chromatography, High Pressure Liquid; Dideoxynucleosides; HIV Seropositivity; Hot Temperature; Humans; Lamivudine; Quality Control; Sensitivity and Specificity; Zalcitabine | 1994 |
Automated high-performance liquid chromatographic analysis of (-)-2'-deoxy-3'-thiacytidine in biological fluids using the automated sequential trace enrichment of dialysate systems.
Topics: Animals; Antiviral Agents; Autoanalysis; Body Fluids; Chromatography, High Pressure Liquid; Dialysis; Humans; Kidney; Lamivudine; Rats; Sensitivity and Specificity; Zalcitabine | 1994 |
Solid-phase extraction combined with radioimmunoassay for measurement of zalcitabine (2',3'-dideoxycytidine) in plasma and serum.
Topics: Antiviral Agents; Biological Availability; Half-Life; Humans; Male; Quality Control; Radioimmunoassay; Sensitivity and Specificity; Zalcitabine; Zidovudine | 1994 |
Mouse lymphoma workshop: Victoria, British Columbia, Canada, March 27, 1996 protocol issues regarding the use of the Microwell Method of the Mouse Lymphoma Assay.
Topics: Adenosine; Animals; Cell Division; Chromosome Aberrations; Dose-Response Relationship, Drug; Lymphoma; Mice; Mutagenicity Tests; Mutation; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Software; Thymidine; Time Factors; Tumor Cells, Cultured; Zalcitabine | 1997 |
The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside.
Topics: Animals; Antineoplastic Agents; Cell Count; Cell Division; Cytarabine; Cytidine Deaminase; Deoxycytidine; HeLa Cells; Humans; Leukemia L1210; Mice; Nucleoside Deaminases; Sensitivity and Specificity; Tumor Cells, Cultured; Zalcitabine | 1992 |